Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cancer Therapy Advisor
A multi-variate analysis published in Cancer Medicine, which includes a population of more than 150,000 individuals, suggests that prior cannabis use was associated with a reduced risk of renal cell carcinoma and bladder cancer in women and prostate cancer in men. A potentially conflicting finding was increased risk of some cancers in current cannabis users.
Oncology, Medical September 6th 2022
PracticeUpdate
This large surgically staged cohort of high-risk patients with preoperative PSMA PET evaluated the accuracy of Ga-68-PSMA-PET/CT for primary nodal staging. The findings suggest that total lesion uptake values could provide valuable presurgical staging information and might aid in predicting risk of lymph node metastasis in patients with prostate cancer.
MDLinx
This summary of a study from Johns Hopkins University says it might just matter how you take your pills – with special implications for bedridden or sedentary patients.
Clinical Pharmacology August 23rd 2022
Endocrine-Related Cancer
The authors engaged in research to attempt to identify circulating biomarkers for pancreatic NETs, to improve tumor surveillance and quality of life. They examined the expression of circulating miRNA in the serum of MEN1 patients and found an inverse relationship between miR-3156-5p and MORF4L2 expression, representing a potential serum biomarker that could facilitate the detection of NET occurrence in MEN1 patients.
Endocrinology, Diabetes, Metabolism August 22nd 2022
Psych Congress Network
After reading this article, head over to this quiz to test your understanding of the findings of a triple-blind, crossover study that involved 173 ADHD-diagnosed children between the ages of 7 and 12. Children received daily education in science, social studies, and vocabulary for 25 minutes over the course of two successive sessions.
Pediatrics August 22nd 2022
Rakesh Jain, MD, MPH, a member of the steering committee for the Psych Congress, and co-authors Huy-Binh Nguyen, PhD, and Mousam Parikh, both of AbbVie, respond to inquiries regarding their study, which discovered a discrepancy between treatment recommendations and the prescription habits of clinicians treating bipolar disorder. The study’s motivation, the most important findings, and suggestions for doctors treating bipolar disorder who want to follow the most recent treatment recommendations are covered in Part 1 of this Q&A.
Psychiatry August 22nd 2022